Table 1.
Therapy | Males | Females | |
---|---|---|---|
Clinical | |||
Thrombolytics | |||
Tissue Plasminogen Activator |
|
|
|
Recombinant Prourokinase Endovascular Intervention |
|
|
|
Cortical Stimulation | |||
rTMS |
|
|
|
rTDS |
|
|
|
Stem Cells | |||
Effects of Cellular Sex |
|
|
|
Transplantation |
|
|
|
Preclinical | |||
Ant i-Inflammation | |||
Minocycline |
|
|
|
Cell Survival | |||
IGF-1 |
|
|
|
anti-Let7F |
|
|
|
Cell Death Inhibition | |||
PARP-1 Inhibition |
|
|
|
Nitric Oxide Reduction |
|
|
|
Caspase Inhibition |
|
|